Table of Contents Print a PDF References Figures & Tables
< Previous Next >

GREGORATOS ET AL., ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices
http://www.acc.org/clinical/guidelines/pacemaker/incorporated/index.htm; 2002

ACC/AHA/NSAPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrythmia Devices—Full Text

A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee on Implantation)

Preamble

It is important that the medical profession play a significant role in critically evaluating the use of diagnostic procedures and therapies in the management or prevention of disease states. Rigorous and expert analysis of the available data documenting relative benefits and risks of those procedures and therapies can produce helpful guidelines that improve the effectiveness of care, optimize patient outcomes, and impact the overall cost of care favorably by focusing resources on the most effective strategies.

The American College of Cardiology (ACC) and the American Heart Association (AHA) have jointly engaged in the production of such guidelines in the area of cardiovascular disease since 1980. This effort is directed by the ACC/AHA Task Force on Practice Guidelines, whose charge is to develop and revise practice guidelines for important cardiovascular diseases and procedures. Experts in the subject under consideration are selected from both organizations to examine subject-specific data and write guidelines. The process includes additional representatives from other medical practitioner and specialty groups where appropriate. Writing groups are specifically charged to perform a formal literature review, weigh the strength of evidence for or against a particular treatment or procedure, and include estimates of expected health outcomes when data exist. Patient specific modifiers, comorbidities, and issues of patient preference that might influence the choice of particular tests or therapies are considered, as well as frequency of follow-up and cost-effectiveness.

The ACC/AHA Task Force on Practice Guidelines makes every effort to avoid any actual or potential conflicts of interest that might arise as a result of an outside relationship or personal interest of a member of the writing panel. Specifically, all members of the writing panel are asked to provide disclosure statements of all such relationships that might be perceived as real or potential conflicts of interest. These statements are reviewed by the parent task force, reported orally to all members of the writing panel at the first meeting, and updated as changes occur. (See Appendix for conflict of interest information for writing committee members.)

These practice guidelines are intended to assist physicians in clinical decision making by describing a range of generally acceptable approaches for the diagnosis, management, or prevention of specific diseases or conditions. These guidelines attempt to define practices that meet the needs of most patients in most circumstances. The ultimate judgment regarding care of a particular patient must be made by the physician and patient in light of all of the circumstances presented by that patient.

The 1997 Committee on Pacemaker Implantation was chaired by Gabriel Gregoratos, MD, FACC, and included the following members: Melvin D. Cheitlin, MD, FACC; Alicia Conill, MD, FACP; Andrew E. Epstein, MD, FACC; Christopher Fellows, MD, FACC; T. Bruce Ferguson, Jr., MD, FACC; Roger A. Freedman, MD, FACC; Mark A. Hlatky, MD, FACC; Gerald V. Naccarelli, MD, FACC; Sanjeev Saksena, MD, MBBS, FACC; Robert C. Schlant, MD, FACC; and Michael J. Silka, MD, FACC. The document update used the 1997 work as its basis. The Committee to Update Guidelines on Cardiac Pacemaker Implantation and Antiarrhythmic Devices was chaired by Gabriel Gregoratos, MD, FACC, FAHA, and included the following members: Andrew E. Epstein, MD, FACC, FAHA; Roger A. Freedman, MD, FACC; David L. Hayes, MD, FACC, FAHA; Mark A. Hlatky, MD, FACC, FAHA; Richard E. Kerber, MD, FACC, FAHA; Gerald V. Naccarelli, MD, FACC, FAHA; Mark H. Schoenfeld, MD, FACC, FAHA; Michael J. Silka, MD, FACC; and Stephen L. Winters, MD, FACC.

The summary article is published in the October 15, 2002 issue of Circulation and the November 6, 2002 issue of the Journal of the American College of Cardiology. The full-text guideline is posted on the ACC, AHA and NASPE Web sites. Copies of the full-text and summary article are available from all three organizations.

 

Raymond J. Gibbons, MD, FACC, FAHA
Chair, ACC/AHA Task Force on Practice Guidelines

Elliott M. Antman, MD, FACC, FAHA
Vice-Chair, ACC/AHA Task Force on Practice Guidelines


© 2002 by the American College of Cardiology Foundation and the American Heart Association, Inc.

Back to Top | | Copyright © 2008 American College of Cardiology
Heart House | 2400 N Street, NW | Washington, DC 20037